Personal finance expert Suze Orman says she’s confident the stock market is headed higher, despite some alarming signs in the ...

AstraZeneca (NASDAQ: AZN) and Pfizer (NYSE: PFE) -- along with one biotech stock, Exelixis (NASDAQ: EXEL). (AstraZeneca): ...

For 1Q25, (Inst.) underperformed the Fund’s benchmark, the Russell 3000 Healthcare Index. Click here to read the full commentary.